YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats

被引：18

作者：

Kawasaki-Yatsugi, S ^{[1
]}

Ichiki, C ^{[1
]}

Yatsugi, S ^{[1
]}

Shimizu-Sasamata, M ^{[1
]}

Yamaguchi, T ^{[1
]}

机构：

[1] Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Pharmacol Lab, Tsukuba, Ibaraki 3058585, Japan

来源：

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 05期

关键词：

YM90K; alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor; focal cerebral ischemia;

D O I：

10.1007/PL00005297

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The neuroprotective effect of YM90K, a potent AMPA receptor antagonist, was examined in rats with permanent and transient occlusion of middle cerebral artery (MCA) using intraluminal suture occlusion method. In rats with permanent MCA occlusions, two types of occluders were used to compare the efficacy of YM90K. When a 4-0 (diameter: 0.19 mm) suture was used, YM90K (20 mg kg(-1) h(-1) i.v. infusion for 4 h) significantly reduced infarct volume (P<0.05) and neurologic deficits (P<0.05) 24 h after MCA occlusion. Infarct volume was also reduced by YM90K at the same dose (P<0.01) when severe ischemia was induced by a 3-0 (diameter: 0.23 mm) suture. In rats with transient (3 h) MCA occlusions, a IO-mg kg(-1) h(-1) dose of YM90K that did not show significant protection in rats with permanent MCA occlusion offered neuroprotective effects. These data demonstrate that YM90K provides cerebral neuroprotection against a wide range of ischemic insults.

引用

页码：586 / 591

页数：6

共 29 条

[11] REPEATED NEGATIVE DC DEFLECTIONS IN RAT CORTEX FOLLOWING MIDDLE CEREBRAL-ARTERY OCCLUSION ARE ABOLISHED BY MK-801 - EFFECT ON VOLUME OF ISCHEMIC-INJURY [J].

IIJIMA, T ;

MIES, G ;

HOSSMANN, KA .

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1992, 12 (05) :727-733

[12] YM90K, AN AMPA ANTAGONIST, HAS NO NEUROTOXIC EFFECTS ON CEREBROCORTICAL NEURONS IN RATS [J].

IZUMISAWA, N ;

KAWAKAMI, A ;

OHATA, T ;

HANADA, T ;

OKEDA, R .

EXPERIMENTAL NEUROLOGY, 1995, 134 (02) :199-204

[13] Neuroprotective effect of YM90K, an AMPA-receptor antagonist, against delayed neuronal death induced by transient global cerebral ischemia in gerbils and rats [J].

KawasakiYatsugi, S ;

Yatsugi, S ;

Koshiya, K ;

ShimizuSasamata, M .

JAPANESE JOURNAL OF PHARMACOLOGY, 1997, 74 (03) :253-260

[14]

KOEK W, 1988, J PHARMACOL EXP THER, V245, P969

[15]

Koizumi J., 1986, JPN J STROKE, V8, P1, DOI [10.3995/jstroke.8.1, DOI 10.3995/JSTROKE.8.1]

[16] PREVENTION OF PERIINFARCT DIRECT-CURRENT SHIFTS WITH GLUTAMATE ANTAGONIST NBQX FOLLOWING OCCLUSION OF THE MIDDLE CEREBRAL-ARTERY IN THE RAT [J].

MIES, G ;

KOHNO, K ;

HOSSMANN, KA .

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1994, 14 (05) :802-807

[17] DIFFUSION AND PERFUSION MAGNETIC-RESONANCE-IMAGING STUDIES TO EVALUATE A NONCOMPETITIVE N-METHYL-D-ASPARTATE ANTAGONIST AND REPERFUSION IN EXPERIMENTAL STROKE IN RATS [J].

MINEMATSU, K ;

FISHER, M ;

LI, LM ;

SOTAK, CH .

STROKE, 1993, 24 (12) :2074-2081

[18]

Okada M., 1992, Society for Neuroscience Abstracts, V18, P87

[19] NMDA ANTAGONIST NEUROTOXICITY - MECHANISM AND PREVENTION [J].

OLNEY, JW ;

LABRUYERE, J ;

WANG, G ;

WOZNIAK, DF ;

PRICE, MT ;

SESMA, MA .

SCIENCE, 1991, 254 (5037) :1515-1518

[20] 2,3-DIHYDROXY-6-NITRO-7-SULFAMOYL-BENZO(F)QUINOXALINE - A NEUROPROTECTANT FOR CEREBRAL-ISCHEMIA [J].

SHEARDOWN, MJ ;

NIELSEN, EO ;

HANSEN, AJ ;

JACOBSEN, P ;

HONORE, T .

SCIENCE, 1990, 247 (4942) :571-574

← 1 2 3 →